HD-OPM Archive
Topics › Plaque, CAC & CT angiography

YELLOW-III 'melting butter' sign: lipid core shrinks and fibrous cap thickens in 6 months

Louis Nervegna · Mar 22, 2026 · ♥ 25 reactions · 11 comments · original Facebook post
Plaque, CAC & CT angiographyPCSK9, ezetimibe & newer drugs
AI summary & key facts

Louis shares Evan Levine's post and explains that YELLOW-III, using near-infrared imaging, showed a major drop in plaque volume driven by the soft lipid core and a major rise in fibrous cap thickness within 6 months of statin plus PCSK9 inhibitor therapy.

Melting away plaque— the “melting butter sign”.

New results from the YELLOW-III study.

Note that these results are discussed (in detail) in a separate post here: ↪ YELLOW-III: statin plus evolocumab thickened fibrous caps over 30% in 6 months.

In just 6 months timeframe, this study showed a major reduction in total plaque volume (PAV), driven primarily by reduction of the soft lipid core (the “butter”) inside plaques. The study also showed a major increase in fibrous cap thickness (FCT) in just 6 months, which is known to stabilize existing plaque.

#reverseHD #statinreverseHD #pcsk9reverseHD #plaqueHD #lipidcoreHD #fibrouscapHD #statinsHD #pcsk9HD #yellowiiiHD #meltingbuttersignHD #pavHD #fctHD

Research cited

Shared from Evan Levine · original post

Beaking News! We can now melt away the fat in your plaque, strengthen the cap and I suspect markedy reduce risk, well beyond the 25% reduction of just adding statins. The "Melting Butter" sign refers to a visual finding in the YELLOW-III study, which used near-infrared spectroscopy (NIRS) imaging to show that high-intensity statin therapy plus Repatha (evolocumab) can stabilize coronary plaques by reducing their lipid content. #healthcare #heart #meltingbutter #heartattack #world

← newer: Muscle contraction after meals clears glucose by a second, iolder: Should you take iron for low-normal ferritin? Probably not w →